Among the diseases causing human death, cardiovascular disease (CVD) remains number
one according to the World Health Organization report in 2021. It is known that …

Background The causal relationship between low-density lipoprotein (LDL) and
atherosclerotic cardiovascular disease (CVD) has been firmly substantiated. LDL consists of …

Objectives The aim of this study was to systematically collate and appraise the available
evidence regarding the associations between small, dense low-density lipoprotein (sdLDL) …

The key role played by low-density lipoprotein (LDL) particles in the pathogenesis of
coronary heart disease (CHD) is well accepted, as is the benefit of lowering LDL in high-risk …

Low‐density lipoprotein (LDL) plays a key role in the development and progression of
atherosclerosis and cardiovascular disease. LDL consists of several subclasses of particles …

Aim: Recent evidence suggests that small dense low-density lipoprotein (sd-LDL) particles
are more atherogenic than large-LDL in spite of their lower cholesterol content. This study …

The National Cholesterol Education Programme Adult Treatment Panel III accepted the
predominance of small dense low-density lipoprotein (sdLDL) as an emerging …

A growing body of data points to sdLDL concentration as a significant determinant of ASCVD
risk. Although future studies should be aimed at determining the clinical benefit of reducing …

Objective—LDLs include particle subclasses that have different mobilities on polyacrylamide
gradient gels: LDL-I (27.2 to 28.5 nm), LDL-IIa (26.5 to 27.2 nm), LDL-IIb (25.6 to 26.5 nm) …

Aims Low-density lipoprotein (LDL) particles cause atherosclerotic cardiovascular disease
(ASCVD) through their retention, modification, and accumulation within the arterial intima …